News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
325,394 Results
Type
Article (10644)
Company Profile (81)
Press Release (314663)
Multimedia
Podcasts (37)
Webinars (12)
Section
Business (86030)
Career Advice (444)
Deals (16779)
Drug Delivery (59)
Drug Development (18250)
Employer Resources (50)
FDA (8518)
Job Trends (7764)
News (133582)
Policy (12335)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1101)
Accelerated approval (14)
Adcomms (4)
Allergies (84)
Alliances (25974)
ALS (43)
Alzheimer's disease (613)
Antibody-drug conjugate (ADC) (100)
Approvals (8869)
Artificial intelligence (394)
Autoimmune disease (53)
Automation (34)
Bankruptcy (114)
Best Places to Work (7001)
BIOSECURE Act (5)
Biosimilars (130)
Biotechnology (51)
Bladder cancer (64)
Brain cancer (21)
Breast cancer (273)
Cancer (1756)
Cardiovascular disease (196)
Career advice (411)
Career pathing (12)
CAR-T (75)
CDC (10)
Cell therapy (254)
Cervical cancer (16)
Clinical research (16520)
Collaboration (1011)
Compensation (154)
Complete response letters (15)
COVID-19 (1093)
CRISPR (52)
C-suite (453)
Cystic fibrosis (35)
Data (2436)
Decentralized trials (2)
Denatured (16)
Depression (60)
Diabetes (227)
Diagnostics (4902)
Digital health (38)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (125)
Drug pricing (96)
Drug shortages (8)
Duchenne muscular dystrophy (82)
Earnings (30104)
Editorial (24)
Employer branding (1)
Employer resources (48)
Events (63346)
Executive appointments (580)
FDA (10323)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (9)
Funding (805)
Gene editing (89)
Generative AI (31)
Gene therapy (233)
GLP-1 (373)
Government (1892)
Grass and pollen (5)
Guidances (250)
Healthcare (11226)
HIV (47)
Huntington's disease (5)
IgA nephropathy (32)
Immunology and inflammation (53)
Immuno-oncology (17)
Indications (57)
Infectious disease (1229)
Inflammatory bowel disease (70)
Inflation Reduction Act (7)
Influenza (55)
Intellectual property (104)
Interviews (53)
IPO (7131)
IRA (22)
Job creations (1052)
Job search strategy (341)
JPM (60)
Kidney cancer (2)
Labor market (27)
Layoffs (123)
Leadership (12)
Legal (2369)
Liver cancer (25)
Longevity (6)
Lung cancer (203)
Lymphoma (145)
Machine learning (25)
Management (22)
Manufacturing (468)
MASH (74)
Medical device (10161)
Medtech (10199)
Mergers & acquisitions (10387)
Metabolic disorders (550)
Multiple sclerosis (88)
NASH (5)
Neurodegenerative disease (116)
Neuropsychiatric disorders (31)
Neuroscience (1073)
Neurotech (1)
NextGen: Class of 2026 (3986)
Non-profit (2169)
Now hiring (10)
Obesity (232)
Opinion (122)
Ovarian cancer (54)
Pain (112)
Pancreatic cancer (65)
Parkinson's disease (88)
Partnered (23)
Patents (201)
Patient recruitment (187)
Peanut (29)
People (26986)
Pharmaceutical (17)
Pharmacy benefit managers (17)
Phase 1 (3810)
Phase 2 (6216)
Phase 3 (7304)
Pipeline (2673)
Policy (102)
Postmarket research (882)
Preclinical (1483)
Press Release (27)
Prostate cancer (108)
Psychedelics (12)
Radiopharmaceuticals (126)
Rare diseases (343)
Real estate (2619)
Recruiting (16)
Regulatory (10206)
Reports (22)
Research institute (1038)
Resumes & cover letters (58)
Rett syndrome (22)
RNA editing (6)
RSV (33)
Schizophrenia (53)
Series A (137)
Series B (110)
Service/supplier (8)
Sickle cell disease (37)
Special edition (8)
Spinal muscular atrophy (48)
Sponsored (28)
Startups (1675)
State (1)
Stomach cancer (2)
Supply chain (66)
Tariffs (26)
The Weekly (21)
Vaccines (355)
Venture capital (48)
Weight loss (144)
Women's health (65)
Worklife (6)
Date
Today (53)
Last 7 days (310)
Last 30 days (1088)
Last 365 days (15154)
2026 (1900)
2025 (15524)
2024 (17487)
2023 (19454)
2022 (27790)
2021 (30549)
2020 (30272)
2019 (26550)
2018 (19373)
2017 (14620)
2016 (14696)
2015 (16683)
2014 (12345)
2013 (10422)
2012 (11053)
2011 (10880)
2010 (8882)
Location
Africa (326)
Alabama (35)
Alaska (3)
Arizona (147)
Arkansas (7)
Asia (17542)
Australia (2184)
California (5085)
Canada (1617)
China (479)
Colorado (310)
Connecticut (218)
Delaware (190)
Europe (43365)
Florida (813)
Georgia (205)
Hawaii (4)
Idaho (47)
Illinois (575)
India (56)
Indiana (407)
Iowa (10)
Japan (234)
Kansas (45)
Kentucky (28)
Louisiana (22)
Maine (33)
Maryland (623)
Massachusetts (3493)
Michigan (215)
Minnesota (427)
Mississippi (5)
Missouri (110)
Montana (21)
Nebraska (17)
Nevada (57)
New Hampshire (56)
New Jersey (1795)
New Mexico (22)
New York (1424)
North Carolina (941)
North Dakota (8)
Northern California (2486)
Ohio (203)
Oklahoma (14)
Oregon (24)
Pennsylvania (1208)
Puerto Rico (7)
Rhode Island (29)
South America (496)
South Carolina (57)
South Dakota (1)
Southern California (1910)
Tennessee (126)
Texas (768)
United States (20001)
Utah (205)
Vermont (1)
Virginia (124)
Washington D.C. (41)
Washington State (367)
West Virginia (3)
Wisconsin (97)
Wyoming (1)
325,394 Results for "ascent healthcare solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gilead Provides Update on Phase 3 ASCENT-07 Study
November 10, 2025
·
16 min read
Press Releases
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
January 22, 2026
·
17 min read
Press Releases
Prothena Provides Update on PRX012 and Announces Results from the Phase 1 ASCENT Clinical Program
August 28, 2025
·
7 min read
Press Releases
Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First-Line Therapy in Patients With Metastatic Triple-Negative Breast Cancer in ASCENT-03 Study
October 19, 2025
·
18 min read
Press Releases
Freya Pharma Solutions Rebrands as Arletta Pharma Solutions, Marking New Phase in Women’s Healthcare Innovation
November 28, 2025
·
4 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Fangzhou and Tencent Healthcare Launch Full-Stack AI Solution for Chronic-Disease Management
November 27, 2025
·
3 min read
Press Releases
YAS Healthcare signs contract for a Proteus®ONE solution, the first proton therapy system to be installed in Dubai, UAE
December 8, 2025
·
2 min read
Press Releases
Ember LifeSciences secures $16.5 million Series A funding to advance breakthrough cold chain solutions for global healthcare
December 17, 2025
·
2 min read
Press Releases
ASCENT-03: Trodelvy® Demonstrates Highly Statistically Significant & Clinically Meaningful Improvement in Progression Free Survival in Patients With First-line Metastatic Triple-Negative Breast Cancer Who Are Not Candidates for Checkpoint Inhibitors
May 23, 2025
·
17 min read
1 of 32,540
Next
